Back to Search
Start Over
RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy
- Source :
- Brain
- Publication Year :
- 2019
- Publisher :
- Oxford University Press (OUP), 2019.
-
Abstract
- TDP-43 is a DNA/RNA binding protein, but whether its interactions with RNA are relevant to inclusion formation in ALS is unclear. Chen et al. report that mutated forms of TDP-43 that are unable to bind RNA have an increased tendency to aggregate, and can mediate toxicity by sequestering wild-type TDP-43.<br />Amyotrophic lateral sclerosis (ALS) presents with focal muscle weakness due to motor neuron degeneration that becomes generalized, leading to death from respiratory failure within 3–5 years from symptom onset. Despite the heterogeneity of aetiology, TDP-43 proteinopathy is a common pathological feature that is observed in >95% of ALS and tau-negative frontotemporal dementia (FTD) cases. TDP-43 is a DNA/RNA-binding protein that in ALS and FTD translocates from being predominantly nuclear to form detergent-resistant, hyperphosphorylated aggregates in the cytoplasm of affected neurons and glia. Mutations in TARDBP account for 1–4% of all ALS cases and almost all arise in the low complexity C-terminal domain that does not affect RNA binding and processing. Here we report an ALS/FTD kindred with a novel K181E TDP-43 mutation that is located in close proximity to the RRM1 domain. To offer predictive gene testing to at-risk family members, we undertook a series of functional studies to characterize the properties of the mutation. Spectroscopy studies of the K181E protein revealed no evidence of significant misfolding. Although it is unable to bind to or splice RNA, it forms abundant aggregates in transfected cells. We extended our study to include other ALS-linked mutations adjacent to the RRM domains that also disrupt RNA binding and greatly enhance TDP-43 aggregation, forming detergent-resistant and hyperphosphorylated inclusions. Lastly, we demonstrate that K181E binds to, and sequesters, wild-type TDP-43 within nuclear and cytoplasmic inclusions. Thus, we demonstrate that TDP-43 mutations that disrupt RNA binding greatly enhance aggregation and are likely to be pathogenic as they promote wild-type TDP-43 to mislocalize and aggregate acting in a dominant-negative manner. This study highlights the importance of RNA binding to maintain TDP-43 solubility and the role of TDP-43 aggregation in disease pathogenesis.
- Subjects :
- Adult
Male
0301 basic medicine
TDP-43
RNA-binding protein
Biology
Protein aggregation
medicine.disease_cause
Protein Aggregation, Pathological
TARDBP
protein aggregation
03 medical and health sciences
0302 clinical medicine
mental disorders
medicine
Humans
Phosphorylation
Amyotrophic lateral sclerosis
Gene
Neurons
Mutation
Neurodegeneration
neurodegeneration
RNA-Binding Proteins
nutritional and metabolic diseases
RNA
Original Articles
medicine.disease
RNA binding protein
nervous system diseases
Cell biology
DNA-Binding Proteins
Editor's Choice
030104 developmental biology
Spinal Cord
TDP-43 Proteinopathies
Neurology (clinical)
ALS
Neuroglia
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 14602156 and 00068950
- Volume :
- 142
- Database :
- OpenAIRE
- Journal :
- Brain
- Accession number :
- edsair.doi.dedup.....1ebce7d635678a4e98f3544e6737cd3b
- Full Text :
- https://doi.org/10.1093/brain/awz313